Sitemap - 2011 - The California Stem Cell Report
San Jose Merc to California Stem Cell Agency: Time to Bow Out
ACT and CIRM: Fresh Life in a Troubled California Stem Cell Courtship?
IOM Looking for New Member for Its CIRM Performance Panel
Stem Cell Awards of the Year: From Geron to iPS 'Warts'
New Multibillion Dollar Stem Cell Bond Measure Wins Endorsement with a Caveat
CIRM's Thomas Blogs on Geron and the Stem Cell Business
Klein, Moral Mandates and Stem Cells
San Jose Mercury News: California Stem Cell Agency Eyeing More Bonds but Has No Treatments
Directors of the California Stem Cell Conclude Meeting
$30 Million 'Disease-in-Dish" Plan Wins Go-ahead from California Stem Cell Agency
California Stem Cell Agency Approves $27 Million To Hasten Stem Cell Therapies
Internet Audiocast of CIRM Directors Meeting Resumes
CIRM Directors Meeting Underway
Los Angeles Times: 'Geron Fiasco' Poses Questions About California Stem Cell Agency
Live Coverage and Public Participation Locations for CIRM Board Meeting Tomorrow
California Stem Cell PR and Spongy Voter Mandates
Researcher Alert: CIRM Making Changes in Grant Administration
Former iPierian Exec Joins California Stem Cell Agency as CFO
The Back Story on Baylis and the Ethics of Geron's hESC Trial
Conflict of Interest: Harvard Researcher Resigns from IOM Inquiry into California Stem Cell Agency
Strategy at CIRM: New Sources of Cash, More Funding Transparency, Better PR?
Luring Stem Cell Researchers to California: A $5.6 Million Bid
California Stem Cell Agency and Geron: Ethical Issues with Sale of hESC Trial
Researcher Alert: CIRM Readying $57 Million in New Opportunities
Stem Cell Agency Provides Early Access to Multimillion Dollar Proposals Coming Before its Directors
Hype, Geron and Stem Cell Research: A Hard-eyed View from the North
The CIRM 'Debt' to George Bush and Disgraced Korean Researcher
California Stem Cell Agency Takes Initiative in PR 'War'
A Look Inside the CIRM-Geron Loan Documents
The Ins and Outs of CIRM's Push to Keep the Geron hESC Effort Alive
California Stem Cell Agency Trying to Line Up Buyers for Geron hESC Business
Geron hESC Withdrawal 'Real Blow' to California Stem Cell Agency, Says CGS
CIRM Chairman on Geron: Agency in for the Long Haul
Possible Buyers for Geron's Stem Cell Business: BioTime, Pfizer, Celgene
Geron Flight from hESC Research is 'Powerful Blow'
Geron Quits Stem Cell Research; Move Deemed Setback to the Field
$127 Million in 'Good News' for San Diego Stem Cell Researchers
Searching for Facts About Cash: CIRM to Treasurer to Finance
Trounson, Parthenotes and International Stem Cell
Stem Cell Agency's Lobbyist Now Ranked No. 1 in California
IOM and California Stem Cell Agency: Study Lacks Key Perspective
Deadline Next Week for Comments on IOM Panelists Examining California Stem Cell Agency
California Stem Cell Agency Approves $68 Million in New Funding
Stem Cell Board Racing Through Agenda
Stem Cell Directors OK New PR Push to Improve CIRM Image
New Collaborative Agreement Announced Between California Stem Cell Agency and NIH
CIRM Directors Break for Lunch; PR Plan Up Next
Stem Cell Directors Discuss Changes in Strategic Plan
CIRM Directors Meeting Underway
Conflicting Start Times for CIRM Board Meeting
CIRM's Next Six Years: Stem Cell Agency Re-examines Its Priorities
Live Coverage of CIRM Board Meeting
Stem Cell Agency PR/Communications Not Up to Snuff, CIRM-funded Report Says
Stem Cell Agency Strikes New Financial Deal with State of California
Gov. Jerry Brown on Borrowing to Finance Stem Cell Research
Stem Cell Agency To Receive $50.8 Million in Additional Funding
More on CIRM's Restriction of Info on Biotech Applicants
California Stem Cell Agency on its Need to Advance Biotech Industry and Restrict Information
California Stem Cell Agency Blogs on European Ban on hESC Patents
CIRM Improves Openness, Provides More Timely, Significant Information for Directors Meeting
Stem Cell Agency Slated for Share of California Bond Sale This Week
IOM Update: Trounson's Absence Tomorrow Due to Prior Speaking Engagement
IOM Begins 'Peak Performance' Review of California Stem Cell Agency
Coming Soon: Fresh Reports from the Stem Cell World
Stem Cell Confab Attracts Modest Media Attention
Andy Grove: More on Speeding Cures
Implications of a Solar Power Debacle for the California Stem Cell Effort
UCSB Reports Peter Coffey's Move from the UK
$30 Million Industry-friendly Plan Moves Forward at California Stem Cell Agency
Andy Grove on Medical Research's Great Pyramid of Egypt
Modest Coverage This Morning of Geron's California Patient
California Stem Cell Agency Beefing Up Ties to Industry
Stem Cell Agency Scores in Coverage of Geron Clinical Trial
New Yorker Examines Stem Cell Architecture at UCSF
High Level Changes at iPierian, a Firm With Deep Roots in California Stem Cell Effort
StemCells Inc. to Sell Real Estate to Raise Cash
Calimmune, the Berlin Patient and $20 Million from California Stem Cell Agency
CIRM Pay: Learning From the Internet's Viral Force
High Salary Stories Hound State Stem Cell Agency
Mentoring and the High Priest Syndrome
Stem Cells Inc. Joining with LaFerla on Alzheimer's Effort
Biotech Industry Scores in Stem Cell Agency Grant Round: Beginning of a Trend?
Britain's Peter Coffey to Join UC Santa Barbara Stem Cell Team
Researcher Alert – Stem Cell Agency Alters Review Procedures on Big Ticket Grants
CIRM Approves Planning Grants for $240 Million Round
Stem Cell Agency Chair Pleased With Likelihood of Fresh Funding
Biotech Industry Alert: California Stem Cell Agency Moves Ahead with Industry-Friendly Efforts
Stem Cell Agency Cuts Travel Under Pressure from Governor
California To Proceed with Fall Bond Sale; Stem Cell Agency Could Benefit
More Information and Earlier for Public on California Stem Cell Issues
California Stem Cell Agency Reviewers Scored Geron Loan Application at 66
Text of CIRM Response on Geron Funding Procedures
Stem Cell Directors Moving on $243 Million Program and Industry-Friendly Efforts
California Stem Cell Achievements: The Perspective from Robert Klein
Faulty Research, Fraud Attract Page One Attention in Wall Street Journal
New Stem Cell Agency Chair Discloses More than $3 Million in Investments
Rao Leaving the Golden State for NIH
$250,000 Stem Cell Agency Performance Audit to Skip its Scientific Performance
Friday Deadline for Nominations for IOM Panel Studying the California Stem Cell Agency
California Stem Cell Agency Chair Sells Interest in Advanced Cell Technology
$150,000 Buyout at Stem Cell Agency in Management Shuffle
Legal Prognostication: Challenge to NIH Stem Cell Funding to End in 2013
Minimal Media Attention to CIRM Reaction to Lawsuit Dismissal
NIH Lawsuit Reaction: CIRM Chair Thomas Touts Research 'Stability' in California
Stem Cell Scientist Says 'Blog or Be Blogged'
NIH Wins Dismissal of Stem Cell Lawsuit
CIRM's King Leaving for Stanford
Implications of Perceptions of Waste and the Stem Cell Agency
Klein's Role as CIRM Chairman Emeritus
August Deadline for Nominations for IOM CIRM Study Panel
CIRM's Trounson and Australian Visiting Professorship
Op-ed in San Jose Merc: Stem Cell Agency a Bust
The Governor on CIRM Chair's $400,000 Salary: The Board Did It
San Jose Mercury News: Stem Cell Bond Proposal Is Financially Spacey
Time to Nominate Members for the IOM Study of the California Stem Cell Agency
Governor Defied; State College Trustees Approve Controversial $400,000 Salary
$400,000 Salary Riles Governor But Not at Stem Cell Agency
State Treasurer's Office Says Stem Cell Report 'Violated Fundamental Principles of Journalism'
Reader Calls for More Context and Comparison on CIRM Salaries
Politics and the Price of Defiance
Hooha over CIRM Salaries: Cheap Shot or Legitimate News?
Simpson on Salary Coverage: Basic Journalism
LA Times Editorial on New CIRM Chair: Tin Ears and Extinction
Minimal Donor Restrictions on Use of Funds by CIRM
Politics and Stem Cells California Style: More to Come in the Next Few Years
CIRM Salaries Spark Outrage from LA Times Readers
LA Times on $400,000 CIRM Chair Salary: Not a Clipping for CIRM to Parade Around
Private Money for Stem Cell Agency: 'Not That Simple'
Thomas: No Conflicts of Interest with Bond Investment Firm
CIRM's New Chair to Sell Stem Cell Stocks Shortly but Continue Link with Bond Firm
Fix on Bad Link to San Diego Editorial
CIRM Media Coverage: PR Problems, Salary Issues and Bond Election
Stem Cell Agency Seeking High Level PR Person; Salary Could Top $200,000
Sacramento Bee: 'CIRM Is In Trouble'
Stem Cell Agency's New Chief Heads for BIO
'A Critical Crossroads:' California Stem Cell Agency's Finances and 'Communications War'
Nature Magazine's Brief Take on CIRM Chair Election
NY Times and San Diego UT on New CIRM Chair; LA Times and SF Chron Ignore Election
Public Already Commenting Negatively on $400,000 Salary for New CIRM Chair
CIRM Directors Adjourn Meeting
Consumer Watchdog: $400,000 CIRM Chair Salary Will Incense Public
More Info on Roll Call on New CIRM Chair
CIRM Board Puts Off Changes in Review of Big Ticket Grants
Trounson's Report Available Online
Roll Call on Election of New CIRM Chair
Stem Cell Directors Resume Meeting in San Diego
Race for the Chair: Political and Financial Pressure Help Thomas Win CIRM Chairmanship
Thomas Elected New Chairman of CIRM
CIRM Directors Still Mulling Chair Selection Privately
CIRM Board Goes Behind Closed Doors
Thomas Stresses His Bond Expertise, Cites State's Dicey Financial Condition
Text of Litvack's Statement to CIRM Board June 22, 2011
Race for the Chair: Litvack Discusses "Black Box" of Bond Financing
CIRM Directors Approve $27 Million Training Effort at State and Community Colleges
$47 Million Training Extension Approved
An Example of Conflict of Interest Issues at CIRM
CIRM Directors Start Chair Election Meeting
Live Coverage of CIRM Chair Election Tonight
Race for the Chair: Blowback, Politics and CIRM Financing
CIRM's Trounson Has Month-Long Gig in Australia in July 2012
Election Night Coverage Planned for CIRM Chair Balloting
State Treasurer Boosts CIRM Chair Candidate with Strong Letter of Support
Right Medicine for CIRM: Front Page Paean to Stem Cell Research
CIRM Director Samuelson on Laggard Information: 'It's crazy. It isn't professional. It bugs me.'
CIRM Posts Details of Change in Big Ticket Grant Reviews
Openness Failure – Public Stiffed on Major California Stem Cell Matters
Stem Cell Blogging from Toronto
CIRM Provides Public With More Info on Next Week's Important Directors' Meeting
CIRM Deficient Again on Informing the Public and Stem Cell Community
California Stem Cell Agency Beefing Up PR, Financial Expertise
Defining a PR Post: CIRM Directors Take a Crack
Reading About Stem Cells in Farsi: An Outreach Effort
High Speed Rail and California Stem Cell Agency on Same Lobbying Track
CIRM Directors Tackle Touchy Management Issues
CIRM Headed for Another Federal Lobbying Effort
From Conflicts of Interest to Unfilled Promises: LA Times Columnist Lambastes CIRM
The Race for the Chair: Weaning CIRM From Government Support
The CIRM Chair Race: Candidate Thomas Touts His Public Finance Experience
Litvack Envisions Oversight Role for CIRM Chair, Shoring Up 'Messaging' and Industry Ties
Advanced Cell Technology and the California Stem Cell Agency
Patent Reform Critics Say Legislation is 'Constitutionally Infirm'
The Candidate's Letters: What Thomas and Litvack Have to Say
CIRM Plans for Lobbyist to Push Patent Reform Position
hESC Patents Piece from San Diego Researchers
The California Stem Cell Agency and Multimillion Dollar Machinations in Washington
Litvack Picks Up Public Support for Bid to Become Chair of Stem Cell Agency
Email to the California Stem Cell Report
Researcher Alert: Fresh Opportunities Looming for CIRM Cash
Opportunities for Public Comment on Nominees for CIRM Chair
Good News for CIRM and Not-So-Good News
CIRM's Klein Honored by Scientists
IOM Study of CIRM: Panel to be Appointed in Fall
CIRM Makes Formal Announcement of Thomas-Litvack Nominations
Nature Says CIRM Faces 'Stark Choice" in New Chairman
Minimal News Coverage on CIRM Chair Nominees
Litvack vs. Thomas for Chair of the $3 Billion Stem Cell Agency
Governor's Nomination Letter for Thomas
$700,000 IOM Study of California Stem Cell Agency to Begin July 1
Newsom to Nominate Thomas for Chair of Stem Cell Agency
Prop. 71 Requirements for Chair of the California Stem Cell Agency
Southern California Investor Nominated for Chair of the State's Stem Cell Agency
Seattle Gilead Exec Is Potential Candidate for Chair of California Stem Cell Agency
Cardiologist/Entrepreneur Eyed for Stem Cell Agency Chair
Klein Makes It Official -- His Last Day is June 23
Southern California Investor Identified as Possible Candidate for CIRM Chair
Latest California Budget Proposal Not the Best News for CIRM
Former Genentech Exec Appointed to CIRM Board
Trounson Joins the Blogging World
California Budget Mess Hamstrings Fresh Funding for Stem Cell Agency
Missing Items: Problems with Blog Host
Geron Loan Draws Media Attention to CIRM
CIRM Directors Tackle Grant Appeal Problems
California Stem Cell Report Cited as One of 25 Best Stem Cell Blogs
California Stem Cell Agency Plans a More Than 16 Percent Budget Boost
California Stem Cell Directors to Huddle on New Chair Candidates
Stem Cell Agency Moving Faster on Budget Preparation
iPSC Bank and Imaging Technology Sessions Offered by CIRM
Look for Candidates for Chair of Stem Cell Agency in Late May
California Budget Mess Threatens CIRM Funding
Sacramento Bee Whacks Pay Plan for New CIRM Chair
Gov. Brown and Others Seek Delay in Filling CIRM Chair Position
State Treasurer Confirms Possible Delay in Stem Cell Bond Sales
Papering over the Pay Problem at CIRM: When is a $400,000 Salary Not $400,000?
California's Bond Sale Suspension, Stem Cells and Cutbacks
Trounson's Views on Grant Terminations at CIRM
More Media Attention on California's Stem Cell Journal Venture
Pera Cites Personal and Professional Reasons for Returning to Australia
Pera Leaving Golden State for Down Under
CIRM Posts Key Information in More Timely Fashion
Real Life and the California Stem Cell Report
CIRM Schedules Action on New Directions for May
CIRM Directors Move to Alter Role of Chair of $3 Billion Stem Cell Program
Stem Cell Directors Adjourn Meeting
CIRM Directors Taking Up Chair Selection
California to Partner with AlphaMed on Stem Cell Research Journal
CIRM Board Reverses Initial Rejection on $1.8 Million Grant
World Stem Cell Summit Garners Support from State Stem Cell Agency
San Leandro Law Firm Awarded $700,000 by California Stem Cell Agency
Another $22 Million to Go to 17 California Stem Cell Research Institutions
CIRM Directors Begin Business Meeting
CIRM Chair Should Back Away from Management Role, Says Top State Official
Stem Cell Directors Conclude Cardiovascular Session
CIRM Directors Begin Meeting Today
Upcoming Coverage this Morning of CIRM Board Meeting
Dual Execs at CIRM Severely Weaken Oversight, CIRM Directors Told
California Stem Cell Agency Ventures into Publishing
CIRM Directors Moving on New Chairman and New Directions for Stem Cell Agency
Geron's Golden Parachute for Okarma
'Nature" Blogs on Chair Selection at $3 Billion Stem Cell Research Effort
Chair of Stem Cell Agency Likely to Remain Part-time Position
From PR to 'Monitoring' Board Members, Klein Spells Out His Routine
More on Positive Feedback Loops at CIRM or "Them That Has Gets"
From Salary to Leadership: Results on CIRM Survey on Criteria for New Chair
Public, Researchers, Industry Left in Dark on CIRM Chair Selection Criteria
Has CIRM Funded Stem Cell Research that Bush Would Have Banned?
Stem Cell Directors Meet Next Thursday to Deal With Klein Replacement
The "Challenges" in a New Multibillion Dollar Stem Cell Bond Election
Okarma's Departure, Pfizer and More
Feeding the Well-fed: Will It Produce the Results CIRM Wants?
Update on Last Week's Hoover and CFAOC Hearings on CIRM
California Stem Cell Agency Already Has Posted Some Statements of Economic Interests
California Stem Cell Agency Hands Out $41 Million
CIRM Directors Conclude Meeting
California Stem Cell Directors Chart New Path to Find New Chairman
CIRM Directors in Executive Session
CIRM Directors to Post Their Statements of Economic Interest Online
Minority Report Filed on Business Application Rejected by Reviewers
Fifth Appeal by Rejected Applicant
Stem Cell Directors Begin Meeting
Coverage of Today's Stem Cell Board Meeting
CIRM Study Says Stem Cell Spending Will Generate 25,000 jobs by 2014
Details Finally Emerge on $200,000 Stem Cell Convention Subsidy Plan
CIRM Directors Move Forward on Selection of New Chairman
State Controller Chiang: Lubin Fills Children's Health Need on CIRM Board
Salk Loses Seat at California's $3 Billion Stem Cell Table
Two State Agencies Looking Into CIRM Tomorrow and Friday
Live Coverage of CIRM Directors Meeting
Late Info Posted for Stem Cell Agency Directors Meeting
IOM Study of California Stem Cell Agency Still Pending
CIRM Stingy with Info on Matters Before Directors This Week
CIRM Beefs Up Technology: More Info and Better Service for Applicants, Grantees Promised
Four Researchers Appeal Grant Reviewer Decisions; Stanford Scientist Cites Broader Concerns
Minimal Coverage of New VP Appointment at CIRM
CIRM Clarifies Directors' Pay Proposal
Amgen Exec Named to New VP Post at California Stem Cell Agency
CIRM Directors to Consider Plan to Pay Some Board Members up to $15,000 Annually
CIRM Directors to Hand Out $40 Million Next Week; Meeting Details Not Available to Public
Oversight Panel to Review CIRM Finances Later This Month
Fresh Approach Urged on CIRM Chair Selection, Self-evaluation of CIRM Board Included
Nature Medicine on CIRM Chair Election
Three Bidders Seek California State Funds for Online Stem Cell Journal
California Stem Cell Agency Says It Unaffected by Suspension of State Bond Sales
California Suspends Bond Sales: Potential Impact on Stem Cell Agency
Science Magazine Assesses CIRM: 'The Good, Bad and Ugly'
Klein Ballyhoos Stem Cell Effort as 'Forever Changing the Future of Human Suffering'